US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 9.450
  • +0.050+0.53%
Close Feb 28 16:00 ET
  • 9.420
  • -0.030-0.32%
Post 20:01 ET
1.01BMarket Cap-3.46P/E (TTM)

Rocket Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.22%273.21M
-0.92%62.69M
6.11%69.42M
7.21%73.71M
8.33%67.38M
16.00%259.66M
-7.73%63.28M
11.87%65.43M
26.83%68.76M
46.12%62.19M
Selling and administrative expenses
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
-General and administrative expense
39.07%101.96M
17.65%25.34M
45.86%27.11M
57.52%27.37M
39.97%22.15M
24.75%73.32M
13.07%21.54M
23.04%18.59M
35.16%17.37M
34.44%15.82M
Research and development costs
-8.10%171.24M
-10.51%37.36M
-9.67%42.32M
-9.80%46.35M
-2.47%45.23M
12.55%186.34M
-16.57%41.74M
7.98%46.84M
24.25%51.38M
50.58%46.37M
Operating profit
-5.22%-273.21M
0.92%-62.69M
-6.11%-69.42M
-7.21%-73.71M
-8.33%-67.38M
-16.00%-259.66M
7.73%-63.28M
-11.87%-65.43M
-26.83%-68.76M
-46.12%-62.19M
Net non-operating interest income expense
2.81%14.46M
-34.60%2.37M
-23.37%2.71M
33.05%4.07M
37.89%5.32M
610.30%14.06M
94.67%3.62M
382.24%3.53M
1,691.67%3.06M
1,023.21%3.86M
Non-operating interest income
2.55%16.35M
-30.55%2.84M
-20.58%3.18M
28.75%4.54M
33.86%5.79M
309.85%15.94M
228.43%4.09M
195.57%4M
426.76%3.52M
594.54%4.33M
Non-operating interest expense
0.59%1.89M
0.64%473K
0.43%471K
0.64%471K
0.64%471K
-1.78%1.88M
176.55%470K
-24.48%469K
-45.64%468K
-55.04%468K
Other net income (expense)
Income before tax
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Income tax
Net income
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Net income continuous Operations
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Minority interest income
Net income attributable to the parent company
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.35%-258.75M
-1.12%-60.33M
-7.79%-66.72M
-6.00%-69.65M
-6.38%-62.05M
-10.70%-245.6M
10.59%-59.66M
-7.17%-61.9M
-20.77%-65.7M
-35.72%-58.34M
Basic earnings per share
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
Diluted earnings per share
6.51%-2.73
3.13%-0.62
5.33%-0.71
9.76%-0.74
9.59%-0.66
10.43%-2.92
28.09%-0.64
13.79%-0.75
1.20%-0.82
-8.96%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.22%273.21M-0.92%62.69M6.11%69.42M7.21%73.71M8.33%67.38M16.00%259.66M-7.73%63.28M11.87%65.43M26.83%68.76M46.12%62.19M
Selling and administrative expenses 39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M
-General and administrative expense 39.07%101.96M17.65%25.34M45.86%27.11M57.52%27.37M39.97%22.15M24.75%73.32M13.07%21.54M23.04%18.59M35.16%17.37M34.44%15.82M
Research and development costs -8.10%171.24M-10.51%37.36M-9.67%42.32M-9.80%46.35M-2.47%45.23M12.55%186.34M-16.57%41.74M7.98%46.84M24.25%51.38M50.58%46.37M
Operating profit -5.22%-273.21M0.92%-62.69M-6.11%-69.42M-7.21%-73.71M-8.33%-67.38M-16.00%-259.66M7.73%-63.28M-11.87%-65.43M-26.83%-68.76M-46.12%-62.19M
Net non-operating interest income expense 2.81%14.46M-34.60%2.37M-23.37%2.71M33.05%4.07M37.89%5.32M610.30%14.06M94.67%3.62M382.24%3.53M1,691.67%3.06M1,023.21%3.86M
Non-operating interest income 2.55%16.35M-30.55%2.84M-20.58%3.18M28.75%4.54M33.86%5.79M309.85%15.94M228.43%4.09M195.57%4M426.76%3.52M594.54%4.33M
Non-operating interest expense 0.59%1.89M0.64%473K0.43%471K0.64%471K0.64%471K-1.78%1.88M176.55%470K-24.48%469K-45.64%468K-55.04%468K
Other net income (expense)
Income before tax -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Income tax
Net income -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Net income continuous Operations -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Minority interest income
Net income attributable to the parent company -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.35%-258.75M-1.12%-60.33M-7.79%-66.72M-6.00%-69.65M-6.38%-62.05M-10.70%-245.6M10.59%-59.66M-7.17%-61.9M-20.77%-65.7M-35.72%-58.34M
Basic earnings per share 6.51%-2.733.13%-0.625.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73
Diluted earnings per share 6.51%-2.733.13%-0.625.33%-0.719.76%-0.749.59%-0.6610.43%-2.9228.09%-0.6413.79%-0.751.20%-0.82-8.96%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.97%
Tesla
TSLA
+3.91%
Disney
DIS
+2.24%
Apple
AAPL
+1.91%
Netflix
NFLX
+1.82%

Unlock the Full List